I'm Buying Extendicare
My Special Situations portfolio invests exclusively in special situations (surprising, isn't it?). And that's what we have in Extendicare . The Canadian health care company is divesting its American unit via a sale or spinoff, and a decision is expected this month on which path it will take. So my Special Situations portfolio is buying in.
The business and special situation
Extendicare is a Canadian company that provides skilled nursing facilities and long-term health care in both the United States and Canada. While the Canadian unit is stable and growing slightly with very high occupancy, the American unit is hampered by governmental cost-cutting, lackluster management, and a toxic political climate. Nevertheless, we are all getting older, and health care remains an attractive cash flow business.
So this is a typical Greenblatt next situation. A divestiture of the American business would improve margins at the parent company and force the market to see the value that it is currently overlooking. But there's true hidden value in the American unit, too. It owns almost all of its real estate in an industry that misprices such owner-operators. The spinoff or sale of the unit should make that value apparent.
Looking at comparable companies, I see substantial upside in the American business. In fact, at today's price I think you're paying nothing for it. Meanwhile, the Canadian unit continues to pay out a 7% dividend yield, a dividend that was cut in May in order to be covered solely by the Canadian operations. It's still a bit unclear whether the company will be able to maintain this payout following the divestiture. It will be close.
On the most recent conference call management said that it expected to announce something by the end of the year. So the word could come at any time.
Foolish bottom line
So that's why I'm buying into Extendicare. I'll be adding $2,700 in shares to my Special Situations portfolio tomorrow. Like it? Hate it? Join me on my discussion board to hash it out.
Another top stock to check out
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
The article I'm Buying Extendicare originally appeared on Fool.com.Jim Royal owns shares of Extendicare. The Motley Fool owns shares of Extendicare. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.